🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
613 medicines starting with “T”
MedicineActive substanceLicence holderStatus
Tambocor 100 mg Tablets
PA23355/023/003
Flecainide acetate Viatris Healthcare Limited Marketed
Tambocor 50 mg Tablets
PA23355/023/002
Flecainide acetate Viatris Healthcare Limited Marketed
Tamiflu 30 mg hard capsules
EU/1/02/222/003
Oseltamivir Roche Registration GmbH
Tamiflu 45 mg hard capsules
EU/1/02/222/004
Oseltamivir Roche Registration GmbH
Tamiflu 6 mg/ml powder for oral suspension
EU/1/02/222/005
Oseltamivir phosphate Roche Registration GmbH
Tamiflu 75 mg hard capsules
EU/1/02/222/001
Oseltamivir phosphate Roche Registration GmbH
Tamnexyl XL 400 micrograms prolonged-release tablets
PA0126/224/001
Tamsulosin hydrochloride Clonmel Healthcare Ltd Marketed
Tamnic 400 microgram hard modified-release capsules
PA0126/395/001
Tamsulosin hydrochloride Clonmel Healthcare Ltd Not marketed
Tamnic 400 micrograms Modified-release Capsules, hard
PA0126/151/001
Tamsulosin hydrochloride Clonmel Healthcare Ltd Marketed
Tamox 10 mg Film-coated tablets
PA0711/022/001
Tamoxifen Rowex Limited, Marketed
Tamox 20 mg film-coated tablets
PA0711/022/002
Tamoxifen Rowex Limited, Marketed
Tamoxifen 20 mg tablets
PA23266/052/001
Tamoxifen Viatris Limited Marketed
TAMSU 400 micrograms modified-release capsules, hard
PA0711/079/001
Tamsulosin hydrochloride Rowex Limited, Marketed
Tamsulosin 400 micrograms Modified-release Capsules, Hard
PA23266/016/001
Tamsulosin hydrochloride Viatris Limited Marketed
Tamsulosin Hydrochloride 400 micrograms Modified-release Capsules, hard
PA0840/013/001
Tamsulosin hydrochloride Synthon BV Not marketed
Tamsulosin Rowa 400 microgram modified-release hard capsules
PA0074/101/001
Tamsulosin hydrochloride Rowa Pharmaceuticals Limited, Not marketed
Tamzeltos 400 micrograms prolonged-release tablets
PA1347/087/001
Tamsulosin hydrochloride KRKA, d.d., Novo mesto Not marketed
Tandemact
EU/1/06/366/005-16
Glimepiride, Pioglitazone CHEPLAPHARM Arzneimittel GmbH
Tandemact
EU/1/06/366/17-22
Glimepiride, Pioglitazone hydrochloride CHEPLAPHARM Arzneimittel GmbH
TANYZ 400 micrograms hard modified-release capsules
PA1347/086/001
Tamsulosin hydrochloride KRKA, d.d., Novo mesto Not marketed
Tapentadol Consilient Health 100 mg film-coated tablets
PA1876/026/003
Tapentadol hydrochloride Consilient Health Limited Marketed
Tapentadol Consilient Health 50 mg film-coated tablets
PA1876/026/001
Tapentadol hydrochloride Consilient Health Limited Marketed
Tapentadol Consilient Health 75 mg film-coated tablets
PA1876/026/002
Tapentadol hydrochloride Consilient Health Limited Marketed
Tapentadol Liconsa 100 mg prolonged-release tablets
PA1239/029/003
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 150 mg prolonged-release tablets
PA1239/029/004
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 200 mg prolonged-release tablets
PA1239/029/005
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 25 mg prolonged-release tablets
PA1239/029/001
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 250 mg prolonged-release tablets
PA1239/029/006
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol Liconsa 50 mg prolonged-release tablets
PA1239/029/002
Tapentadol tartrate Laboratorios Liconsa S.A. Not marketed
Tapentadol MSN 100 mg prolonged-release tablets
PA23250/009/003
Tapentadol tartrate MSN Labs Europe Limited Not marketed
Tapentadol MSN 150 mg prolonged-release tablets
PA23250/009/004
Tapentadol tartrate MSN Labs Europe Limited Not marketed
Tapentadol MSN 200 mg prolonged-release tablets
PA23250/009/005
Tapentadol tartrate MSN Labs Europe Limited Not marketed
Tapentadol MSN 25 mg prolonged-release tablets
PA23250/009/001
Tapentadol tartrate MSN Labs Europe Limited Not marketed
Tapentadol MSN 250 mg prolonged-release tablets
PA23250/009/006
Tapentadol tartrate MSN Labs Europe Limited Not marketed
Tapentadol MSN 50 mg prolonged-release tablets
PA23250/009/002
Tapentadol tartrate MSN Labs Europe Limited Not marketed
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
PA0879/003/001
Tafluprost, Timolol Santen OY Marketed
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
PPA0465/475/001
Tafluprost, Timolol PCO Manufacturing Ltd.
Tarceva 100mg film-coated tablets
EU/1/05/311/002
Erlotinib hydrochloride Cheplapharm Registration GmbH
Tarceva 150 mg film-coated tablets
EU/1/05/311/003
Erlotinib hydrochloride Cheplapharm Registration GmbH
Tarceva 25 mg film-coated tablets
EU/1/05/311/001
Erlotinib hydrochloride Cheplapharm Registration GmbH
Targaxan 550 mg film-coated tablets
PA1336/009/001
Rifaximin Norgine B.V. Marketed
Targin 10 mg/5 mg prolonged-release tablets
PPA0465/512/002
Oxycodone hydrochloride, Naloxone hydrochloride PCO Manufacturing Ltd.
Targin 10mg/5mg prolonged-release tablets
PA1688/010/002
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Targin 15 mg/7.5 mg prolonged-release tablets
PA1688/010/006
OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
Targin 20 mg/10 mg prolonged-release tablets
PPA0465/512/003
Oxycodone hydrochloride, Naloxone hydrochloride PCO Manufacturing Ltd.
Targin 20mg/10mg prolonged-release tablets
PA1688/010/003
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Targin 30 mg/15 mg prolonged-release tablets
PA1688/010/007
OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE Mundipharma Pharmaceuticals Limited Marketed
Targin 40 mg/20 mg prolonged-release tablets
PA1688/010/004
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
Targin 40 mg/20 mg prolonged-release tablets
PPA0465/512/004
Oxycodone hydrochloride, Naloxone hydrochloride dihydrate PCO Manufacturing Ltd.
Targin 5 mg/2.5 mg prolonged-release tablets
PA1688/010/001
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate Mundipharma Pharmaceuticals Limited Marketed
1 2 3 4 5
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.